Associations of polycyclic aromatic hydrocarbons exposure with serum uric acid and hyperuricemia in US adults: The role of systemic inflammation
Journal of Environmental Sciences · 2025
DOI: 10.1016/j.jes.2024.01.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Environmental Sciences, 2025. Verfasst von Yang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, …. Hauptthemen laut MEDLINE: Polycyclic Aromatic Hydrocarbons, Uric Acid, Inflammation, Hyperuricemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
The associations of polycyclic aromatic hydrocarbon (PAH) exposure with serum uric acid (SUA) or hyperuricemia have been rarely assessed. We aimed to investigate the relationships between urinary PAH metabolites and SUA or hyperuricemia among US adults and to explore the mediating role of systemic inflammation in the associations. A total of 10,307 US adults were conducted to assess the associations of seven urinary hydroxy‑PAH with SUA and hyperuricemia and evaluate the role of C-reactive protein (CRP), a biomarker of systemic inflammation, in such associations. Results showed that each 1-unit increase in ln-transformed 2-hydroxynaphthalene (2-OHNa), 1-hydroxyphenanthrene (1-OHPh), 2&3-hydroxyphenanthrene (2&3-OHPh) and total hydroxyphenanthrene (ΣOHPh) was associated with a 1.68 (95% confidence interval (CI): 0.19 to 3.17), 2.46 (0.78 to 4.13), 3.34 (1.59 to 5.09), and 2.99 (1.23 to 4.75) µmol/L increase in SUA, and a 8% (odds ratio (OR): 1.08, 1.02 to 1.15), 9% (OR: 1.09, 1.02 to 1.18), 13% (OR: 1.13, 1.05 to 1.22), and 12% (OR: 1.12, 95% CI: 1.03, 1.21) increase in hyperuricemia, respectively. Co-exposure of seven PAHs was positively associated with SUA and hyperuricemia, with 2&3-OHPh showing the highest weight (components weights: 0.83 and 0.78, respectively). The CRP mediated 11.47% and 10.44% of the associations of ΣOHPh and 2&3-OHPh with SUA and mediated 8.60% and 8.62% in associations of ΣOHPh and 2&3-OHPh with hyperuricemia, respectively. In conclusion, internal levels of PAH metabolites were associated with elevated SUA levels and the increased risk of hyperuricemia among US adults, and CRP played a mediating role in the associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 4300230, China; Key Laboratory of Environment and Health, Minist…
- Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, AB, T6G 2R3, Canada.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Liu, Y., Ding, X., Yu, L., Shi, D., Liang, R., Liu, W., Huang, X., Cao, X., Zhou, M., & Chen, W. (2025). Associations of polycyclic aromatic hydrocarbons exposure with serum uric acid and hyperuricemia in US adults: The role of systemic inflammation. Journal of Environmental Sciences. https://doi.org/10.1016/j.jes.2024.01.043
Vancouver
Liu Y, Ding X, Yu L, Shi D, Liang R, Liu W, et al. Associations of polycyclic aromatic hydrocarbons exposure with serum uric acid and hyperuricemia in US adults: The role of systemic inflammation. Journal of Environmental Sciences. 2025. doi:10.1016/j.jes.2024.01.043
BibTeX
@article{Liu2025,
author = {Liu, Yang and Ding, Xuejie and Yu, Linling and Shi, Da and Liang, Ruyi and Liu, Wei and Huang, Xuezan and Cao, Xiuyu and Zhou, Min and Chen, Weihong},
title = {Associations of polycyclic aromatic hydrocarbons exposure with serum uric acid and hyperuricemia in US adults: The role of systemic inflammation},
journal = {Journal of Environmental Sciences},
year = {2025},
doi = {10.1016/j.jes.2024.01.043}
}
EUVIMED